Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Between A Rock Creek And A Hard Place: Firm Stops Supplement Sales, Weathers Litigation

This article was originally published in The Tan Sheet

Executive Summary

Rock Creek Pharmaceuticals faces investor and consumer class-action complaints on top of ending sales of its nutritionals following an FDA warning. Moreover, the company name is known more in connection with federal officials’ investigation of the former governor of Virginia than for its products.

You may also be interested in...



Industry Roundup: GMPs, DXM, Pharmascience, Rock Creek

Herbal firm crosses GMP, claims lines; Kentucky makes 8 to age-restrict DXM sales; Pharmascience expands with Quebec support; Rock Creek closes share offerings; and more news in brief.

Industry Roundup: GMPs, DXM, Pharmascience, Rock Creek

Herbal firm crosses GMP, claims lines; Kentucky makes 8 to age-restrict DXM sales; Pharmascience expands with Quebec support; Rock Creek closes share offerings; and more news in brief.

Industry News Roundup

DASCA facilitates DEA’s steroid scheduling; U.K. ad authority sneezes at hay fever claim; Nutroganics acquires Wholesoy; hemp migraine relief distribution lit; Clif’s cashew recipe trips some customers; ONHA sponsors GrassrootsHealth nutrient research; baby wipe recall reaches 4M units; and Nasdaq reprieve for Rock Creek.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS107096

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel